• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 和 HIV-1:细胞和分子水平上如此不同却又如此相似的免疫反应。

SARS-CoV-2 and HIV-1: So Different yet so Alike Immune Response at the Cellular and Molecular Level.

机构信息

Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, 46 Makedonitissas Avenue, 2417, Nicosia, Cyprus.

出版信息

Int J Med Sci. 2022 Oct 3;19(12):1787-1795. doi: 10.7150/ijms.73134. eCollection 2022.

DOI:10.7150/ijms.73134
PMID:36313221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9608044/
Abstract

In the past half century, humanity has experienced two devastating pandemics; the HIV-1 pandemic and the recent pandemic caused by SARS-CoV-2. Both emerged as zoonotic pathogens. Interestingly, SARS-CoV-2 has rapidly migrated all over the world in less than two years, much as HIV-1 did almost 40 years ago. Despite these two RNA viruses being different in their mode of transmission as well as the symptoms they generate, recent evidence suggests that they cause similar immune responses. In this mini review, we compare the molecular basis for CD4 T cell lymphopenia and other effects on the immune system induced by SARS-CoV-2 and HIV-1 infections. We considered features of the host immune response that are shared with HIV-1 and could account for the lymphopenia and other immune effects observed in COVID-19. The information provided herein, may cast the virus-induced lymphopenia and cytokine storm associated with the acute SARS-CoV-2 infection and pathogenesis in a different light for further research on host immune responses. It can also provide opportunities for the identification of novel therapeutic targets for COVID-19. Furthermore, we provide some basic information to enable a comparative framework for considering the overlapping sets of immune responses caused by HIV-1 and SARS-CoV-2.

摘要

在过去的半个世纪里,人类经历了两次毁灭性的大流行:HIV-1 大流行和最近由 SARS-CoV-2 引起的大流行。这两种病毒都是人畜共患病原体。有趣的是,SARS-CoV-2 在不到两年的时间里迅速传播到世界各地,就像 HIV-1 近 40 年前那样。尽管这两种 RNA 病毒在传播方式和引起的症状上有所不同,但最近的证据表明,它们会引起相似的免疫反应。在这篇迷你综述中,我们比较了 SARS-CoV-2 和 HIV-1 感染引起 CD4 T 细胞淋巴细胞减少和对免疫系统的其他影响的分子基础。我们考虑了与 HIV-1 共享的宿主免疫反应的特征,这些特征可能解释了 COVID-19 中观察到的淋巴细胞减少和其他免疫效应。本文提供的信息,可以为进一步研究宿主免疫反应,提供与急性 SARS-CoV-2 感染和发病机制相关的病毒诱导的淋巴细胞减少和细胞因子风暴的新视角。它也为识别 COVID-19 的新型治疗靶点提供了机会。此外,我们提供了一些基本信息,以便为考虑 HIV-1 和 SARS-CoV-2 引起的重叠免疫反应提供一个比较框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef4/9608044/1348558ecb76/ijmsv19p1787g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef4/9608044/1348558ecb76/ijmsv19p1787g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ef4/9608044/1348558ecb76/ijmsv19p1787g001.jpg

相似文献

1
SARS-CoV-2 and HIV-1: So Different yet so Alike Immune Response at the Cellular and Molecular Level.SARS-CoV-2 和 HIV-1:细胞和分子水平上如此不同却又如此相似的免疫反应。
Int J Med Sci. 2022 Oct 3;19(12):1787-1795. doi: 10.7150/ijms.73134. eCollection 2022.
2
SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147.SARS-CoV-2 相关的淋巴细胞减少症:可能的机制和 CD147 的作用。
Cell Commun Signal. 2024 Jul 4;22(1):349. doi: 10.1186/s12964-024-01718-3.
3
Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia.特发性CD4淋巴细胞减少症患者对SARS-CoV-2 mRNA疫苗的免疫反应。
J Allergy Clin Immunol. 2024 Feb;153(2):503-512. doi: 10.1016/j.jaci.2023.10.012. Epub 2023 Oct 28.
4
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.针对 SARS-CoV-2 的免疫反应和 COVID-19 中免疫病理变化的机制。
Allergy. 2020 Jul;75(7):1564-1581. doi: 10.1111/all.14364.
5
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.HIV-1与新型冠状病毒:两种大流行病原体的进化模式
Cell Host Microbe. 2021 Jul 14;29(7):1093-1110. doi: 10.1016/j.chom.2021.05.012. Epub 2021 Jun 3.
6
SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.SARS-CoV-2 将不断扫荡其踪迹:一种含有 CpG 基序的“套索”疫苗,针对多面病毒。
Inflamm Res. 2020 Sep;69(9):801-812. doi: 10.1007/s00011-020-01377-3. Epub 2020 Jul 12.
7
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.SARS-CoV-2 感染期间免疫反应概述:从过去中吸取的教训。
Front Immunol. 2020 Aug 7;11:1949. doi: 10.3389/fimmu.2020.01949. eCollection 2020.
8
Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.新型冠状病毒病 2019(COVID-19):免疫病理学、血清学诊断和治疗概述。
Scand J Immunol. 2021 Apr;93(4):e12998. doi: 10.1111/sji.12998. Epub 2020 Dec 3.
9
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.SARS-CoV、MERS-CoV 和 SARS-CoV-2 感染中的免疫致病反应和血液病理效应的重点。
Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020.
10
SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationale.SARS-CoV-2 可能通过直接抑制 T 细胞受体来影响免疫反应:机制假说和原理。
Biochimie. 2022 Apr;195:86-89. doi: 10.1016/j.biochi.2021.11.005. Epub 2021 Nov 15.

引用本文的文献

1
Comparative Analysis of Virology and Pathogenesis of SARS-CoV-2 and HIV Infections: Implications for Public Health and Treatment Strategies.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与人类免疫缺陷病毒(HIV)感染的病毒学及发病机制比较分析:对公共卫生和治疗策略的启示
Infect Drug Resist. 2025 Jan 15;18:269-283. doi: 10.2147/IDR.S498430. eCollection 2025.
2
CD4+ and CD8+ cell counts are significantly correlated with absolute lymphocyte count in hospitalized COVID-19 patients: a retrospective study.住院 COVID-19 患者的 CD4+和 CD8+细胞计数与绝对淋巴细胞计数显著相关:一项回顾性研究。
PeerJ. 2023 Jun 23;11:e15509. doi: 10.7717/peerj.15509. eCollection 2023.
3

本文引用的文献

1
High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.高维分析揭示了 COVID-19 中粒细胞的表型异质性和疾病特异性改变。
Proc Natl Acad Sci U S A. 2021 Oct 5;118(40). doi: 10.1073/pnas.2109123118.
2
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.HIV-1与新型冠状病毒:两种大流行病原体的进化模式
Cell Host Microbe. 2021 Jul 14;29(7):1093-1110. doi: 10.1016/j.chom.2021.05.012. Epub 2021 Jun 3.
3
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.
The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications.
COVID-19 对 HIV-1 感染者和 HIV-1 相关神经并发症的影响。
Viruses. 2023 May 5;15(5):1117. doi: 10.3390/v15051117.
4
Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future.SARS-CoV-2 和 HIV 表面包膜糖蛋白的趋同进化动力学受宿主细胞表面受体和脂筏驱动:对未来的启示。
Int J Mol Sci. 2023 Jan 18;24(3):1923. doi: 10.3390/ijms24031923.
5
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines.对SARS-CoV-2的T细胞介导免疫反应的最新见解:迈向高效可靠疫苗的一步。
Vaccines (Basel). 2023 Jan 1;11(1):101. doi: 10.3390/vaccines11010101.
DC/L-SIGN对刺突糖蛋白的识别促进了SARS-CoV-2的转染,并且可以被一种糖模拟拮抗剂所抑制。
PLoS Pathog. 2021 May 20;17(5):e1009576. doi: 10.1371/journal.ppat.1009576. eCollection 2021 May.
4
Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!白细胞介素-6、CXCL10 和浸润巨噬细胞在 COVID-19 相关细胞因子风暴中的作用:不是一荣俱荣,而是众志成城!
Front Immunol. 2021 Apr 26;12:668507. doi: 10.3389/fimmu.2021.668507. eCollection 2021.
5
Type I and III interferon responses in SARS-CoV-2 infection.SARS-CoV-2 感染中的 I 型和 III 型干扰素反应。
Exp Mol Med. 2021 May;53(5):750-760. doi: 10.1038/s12276-021-00592-0. Epub 2021 May 6.
6
Functional landscape of SARS-CoV-2 cellular restriction.SARS-CoV-2 细胞限制的功能景观
Mol Cell. 2021 Jun 17;81(12):2656-2668.e8. doi: 10.1016/j.molcel.2021.04.008. Epub 2021 Apr 13.
7
A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).新型冠状病毒(SARS-CoV-2)免疫反应综述。
Immunol Res. 2021 Jun;69(3):213-224. doi: 10.1007/s12026-021-09198-0. Epub 2021 Apr 29.
8
Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses.RNA病毒对NLRP3炎性小体的激活与抑制
J Inflamm Res. 2021 Mar 26;14:1145-1163. doi: 10.2147/JIR.S295706. eCollection 2021.
9
SARS-CoV-2 re-infection: development of an epidemiological definition from India.SARS-CoV-2 再感染:来自印度的流行病学定义的制定。
Epidemiol Infect. 2021 Mar 26;149:e82. doi: 10.1017/S0950268821000662.
10
NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients.NLRP3炎性小体导致慢性HIV-1感染患者的CD4+ T细胞损失。
J Clin Invest. 2021 Mar 15;131(6). doi: 10.1172/JCI138861.